rxstat › Shortages › Aripiprazole

Aripiprazole (Abilify, Abilify Maintena) shortage status

No current shortage

Source: Health Canada shortage reports · Updated Oct 30, 2026

Aripiprazole has no current shortage reported in Canada. It has been in shortage before; the history is below.

An antipsychotic used to treat schizophrenia and bipolar disorder.

Products affected
0 / 31
Reports on file
128

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Resolved
APO-ARIPIPRAZOLE
20MG · TABLET · APOTEX INC
DIN 02471124 · ended Oct 30, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-ARIPIPRAZOLE
20MG · TABLET · APOTEX INC
DIN 02471124 · ended Oct 30, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-ARIPIPRAZOLE
5MG · TABLET · APOTEX INC
DIN 02471094 · ended Jul 2, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-ARIPIPRAZOLE
10MG · TABLET · APOTEX INC
DIN 02471108 · ended Jul 2, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-ARIPIPRAZOLE
2MG · TABLET · APOTEX INC
DIN 02471086 · ended Jul 9, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-ARIPIPRAZOLE
5MG · TABLET · APOTEX INC
DIN 02471094 · ended Jul 2, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-ARIPIPRAZOLE
10MG · TABLET · APOTEX INC
DIN 02471108 · ended Jul 2, 2026 · Disruption of the manufacture of the drug.
Resolved
ARIPIPRAZOLE
20MG · TABLET · SANIS HEALTH INC
DIN 02506750 · ended Oct 21, 2026 · Disruption of the manufacture of the drug.
Resolved
SANDOZ ARIPIPRAZOLE
10MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02473674 · ended Oct 13, 2026 · Delay in shipping of the drug.
Resolved
APO-ARIPIPRAZOLE
2MG · TABLET · APOTEX INC
DIN 02471086 · ended Jul 9, 2026 · Disruption of the manufacture of the drug.
Resolved
ABILIFY MAINTENA
400MG · KIT POWDER FOR SUSPENSION, SUSTAINED-RELEASE · OTSUKA PHARMACEUTICAL CO LTD
DIN 02420872 · ended Jun 26, 2026 · Disruption of the manufacture of the drug.
Resolved
AURO-ARIPIPRAZOLE
30MG · TABLET · AURO PHARMA INC
DIN 02460084 · ended Jan 20, 2026 · Demand increase for the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

There are no active shortage reports for Aripiprazole. Health Canada has 128 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Aripiprazole is classified under “ANTIPSYCHOTICS” (ATC N05AX).

Recent changes

Common questions

What is Aripiprazole used for?

An antipsychotic used to treat schizophrenia and bipolar disorder.

When will Aripiprazole be back in stock in Canada?

Aripiprazole has no active shortage; supply is normal per Health Canada reports.

Why is Aripiprazole in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (antipsychotics)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.